Skip to main content
NEUROONE MEDICAL TECHNOLOGIES Corp logo

NEUROONE MEDICAL TECHNOLOGIES Corp — Investor Relations & Filings

Ticker · NMTC ISIN · US64130M2098 US Manufacturing
Filings indexed 634 across all filing types
Latest filing 2026-01-02 Director's Dealing
Country US United States of America
Listing US NMTC

About NEUROONE MEDICAL TECHNOLOGIES Corp

https://nmtc1.com/

NeuroOne Medical Technologies Corp. is a medical technology company developing and commercializing solutions based on its proprietary thin-film electrode platform. The company provides minimally invasive and high-definition devices for diagnostic and therapeutic neurological applications, including brain recording, mapping, stimulation, and radiofrequency (RF) ablation. Its primary focus is on conditions such as drug-resistant epilepsy and the neurostimulation market. Key products include the Evo® sEEG and Cortical electrodes for brain monitoring and the OneRF™ Ablation System, an FDA-cleared device that combines stereoelectroencephalography (sEEG) recording with RF ablation capabilities for functional neurosurgical procedures. The company's technology aims to improve surgical care options and outcomes for patients with neurological disorders.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2026-01-02 English
CURRENT REPORT
Regulatory Filings
2025-12-22 English
NeuroOne(R) Appoints Jason Mills to the Board of Directors
Board/Management Information Classification · 1% confidence The document is a corporate press release announcing the appointment of a new member, Jason Mills, to the Board of Directors of NeuroOne Medical Technologies. This falls directly under the definition of 'Board/Management Information' (MANG), which covers announcements of changes in the company's board of directors or senior management.
2025-12-22 English
REGISTRATION STATEMENT
Registration Form
2025-12-19 English
CURRENT REPORT
Regulatory Filings
2025-12-17 English
NeuroOne Reports Strong Fourth Quarter Fiscal 2025 Financial Results With Product Revenue Growth of 907% to $2.7 Million and 55.8% Gross Margin & Total Revenue Growth of 163% to $9.1 Million for F
Earnings Release Classification · 1% confidence The document is a press release issued by NeuroOne Medical Technologies announcing their fourth quarter and full fiscal year 2025 financial results. It contains key financial highlights, management commentary, operational updates, and details regarding an upcoming conference call. It is not a full 10-K report, but rather the initial announcement of financial results, which fits the definition of an Earnings Release (ER). Q4 2025
2025-12-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.